Analysis of adult vaccination in Shandong Province from 2018 to 2022.
10.3760/cma.j.cn112150-20230607-00444
- Author:
Wei Yan ZHANG
1
;
Ren Peng LI
2
;
Yang YU
3
;
Ying Jie ZHANG
4
;
Hui Feng SUN
1
;
Ai Qiang XU
1
Author Information
1. Department of EPI Management, Shandong Center for Disease Control and Prevention, Ji'nan 250014, China.
2. Shandong Provincial Institute for Endemic Disease Control, Ji'nan 250014, China.
3. Department of EPI Management, Weihai Center for Disease Control and Prevention, Weihai 264200, China.
4. Department of Human Resource/Department of Party and Masses Work, Shandong Center for Disease Control and Prevention, Ji'nan 250014, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Humans;
Young Adult;
Aged;
Middle Aged;
Adolescent;
Aged, 80 and over;
Papillomavirus Infections;
Vaccination;
Phenylbutyrates;
Influenza Vaccines
- From:
Chinese Journal of Preventive Medicine
2023;57(12):2021-2028
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the utilization of adult vaccination among people aged 18 and above in Shandong Province from 2018 to 2022. Methods: Data on vaccination units in 2022 and individual cases of vaccination information for people aged 18 and above were extracted from the Shandong Immunization Information System. A descriptive analysis was conducted on the distribution of adult vaccination units and adult vaccination varieties. The total vaccination amount and vaccination rate were calculated. Results: By the end of 2022, there were 3 948 vaccination units providing adult vaccination in Shandong Province, with 0.36 adult vaccination clinics per 10 000 people. Adult vaccination including RabV(rabies vaccine for human use), InfV(influenza vaccine), HPV(human papillomavirus), HepB(hepatitis B vaccine), PPV23(23-valent pneumococcal polysaccharide vaccine), MenACYW135(meningococcal polysaccharide vaccine group ACYW135), MMR(measles, mumps and rubella combined attenuated live vaccine), HEV(hepatitise E vaccine), RZV(recombinant zoster vaccine), TV(tetanus vaccine) and HF(haemorrhagic fever with renal syndrome vaccine) vaccines were administered, with a cumulative dose of 40.056 9 million and an average of 0.1 doses per person per year from 2018 to 2022. The top three vaccines were RabV, InfV and HPV, accounting for 31.48%, 22.57%, and 15.93% of the total vaccination amount, respectively. The annual vaccination dose for adults increased from 3.477 3 million in 2018 to 13.308 6 million in 2022, with an average annual growth rate of 56.55%. The cumulative 5-year doses of RabV and TV were 15.90 doses per 100 people and 0.21 doses per 100 people. The average annual vaccination rate of InfV was 2.28%. The cumulative full vaccination rates of HPV, HepB, PPV23 and RZV were 12.44%, 1.61%, 0.52% and 0.17%, respectively. The cumulative 5-year doses of RabV and TV were 29.19 doses per 100 people and 0.43 doses per 100 people in the age group of 20 to<30 years old. The vaccination rates of InfV and PPV23 were 9.08% and 1.27% in the age group of 70 to<80 years old. The vaccination rate of RZV was 0.11% in the age group of 50 to<60 years old. The HPV vaccination rate was 18.09% in the age group of 20 to<30 years old, and the HepB, MenACYW135, MMR and HEV vaccination rates were 6.21%, 9.55%, 2.65%, and 2.83% in the 18-19 age group, respectively. Conclusion: There are relatively few types of adult vaccination in Shandong Province, with narrow coverage and low vaccination rates.
